Peptide library

Who was in the BPC-157 studies?
Sex, age and exclusions

Whom the studies enrolled, by sex and age, and whom the registered trials leave out, quoted as study criteria. This page describes study design, not advice. Dated 21 November 2026.

Short answerCompound research · 6 min read · Updated 21 Nov 2026

We found six published studies that gave BPC-157 to people, 118 participants in all, and four registered trials with no posted results (21 November 2026). Fifteen participants were women; the sources describe 33 as men and give no sex for 70. We found no human study in pregnancy, and all four registered trials exclude pregnancy and breastfeeding.

Key takeaways

  • We found six published studies that gave BPC-157 to people, 118 participants in all, most without a control group (PubMed and FDA’s 2026 review, 21 Nov 2026).
  • By our count from the sources, 15 participants were women and 33 men, 32 of them volunteers whose 2003 abstract title calls them male; the sources do not give the sex of 70.
  • The one study that enrolled only women had 12 participants aged 39 to 76 and no control group.
  • All four records on ClinicalTrials.gov accept both sexes, set a minimum age of 18 and exclude pregnancy and breastfeeding; one also excludes people in a formal anti-doping testing programme unless the relevant authority approves.
  • Of 109 PubMed records of BPC-157 animal studies, 83 carry only the male tag and 12 only the female tag (our count, 21 Nov 2026).

01Who was in the BPC-157 studies, at a glance

If you searched “bpc-157 for women”, the question the studies can answer is narrower: whom they enrolled, by sex and age, and whom they left out. This page describes study design. It gives no advice about any person.

People · 34

Healthy volunteers

Two studies enrolled people the authors describe as healthy: 32 in conference abstracts from 2002 and 2003, and 2 in a 2025 pilot.

People · 84

Patients

Four studies enrolled patients: 53, 16, 12 and 3. The 12 were all women; the 3 received BPC-157 with other agents.

Animals · mostly male

Rats and mice

Of 109 PubMed records of BPC-157 animal studies, 83 carry only the male tag, as PubMed indexes them (our count).

Six studies, 118 people, most of them without a control group: every published study we found that gave BPC-157 to people (PubMed and FDA’s 2026 review, 21 November 2026). Reports made to FDA are a separate record; they show no cause and no rate. Why the grade stays Preclinical, and where BPC-157 stands with regulators: the BPC-157 guide.

02Who was in each published BPC-157 study?

Every published study we found that gave BPC-157 to people, with what its source says about sex and age.

StudyDesignPeopleSexAge
Veljaca et al., 2002 and 2003Randomised, placebo-controlled; conference abstracts, summarised by FDA staff32 healthy volunteers, 24 given BPC-157Male, in the title of the 2003 abstractNot given in FDA’s summary
Ruenzi et al., 2005Randomised, placebo-controlled; conference abstract, summarised by FDA staff53 patients; 46 completedNot givenNot given
Lee and Padgett, 2021Chart review with a phone survey; no control group17 patients identified, 16 reachedNot given in the abstractNot given in the abstract
Lee, Walker and Ayadi, 2024Single group; no control group12 patientsAll women39 to 76; mean 58.3
Lee and Burgess, 2025Two-person pilot; no control group2 adults described as healthy, both given BPC-157 before the studyOne man, one woman58 and 68
Froum et al., 2026Case report; no control group3 patients given BPC-157 with TB-500 and other agentsTwo women; one not stated38, 48 and 85

How we counted. Our calculation from the six sources: 15 women (12 + 1 + 2), 33 men (32 + 1) and 70 people whose sex the sources we read do not give (53 + 16 + 1). The 32 are counted as men because the title of the 2003 abstract, as FDA’s 2026 review lists it, describes “Healthy Male Volunteers”; we could not read the abstract itself. Ages are given for 17 of the 118.

The patient groups were defined by specific conditions, named on BPC-157 human studies with each study’s design. A 2026 systematic review of the three full papers, 30 people, rated the certainty of the evidence “very low”.

03Whom do the registered BPC-157 trials include and exclude?

ClinicalTrials.gov lists four records that give BPC-157 (21 November 2026). Each states who may take part. None has posted results, so none shows who actually took part.

RecordDesign and statusSexesAgesHealthy volunteersExclusions, quoted from the record
NCT02637284Phase 1, randomised, placebo-controlled; 42 planned; status unknown, last updated Dec 2015“Both genders”18 to 35Yes“Pregnant or lactating women”
NCT07752381Single group, no control; 40 enrolled; completed Nov 2025; no results posted“male or female”18 to 65Yes“Any women who are pregnant, breastfeeding, or trying to conceive”
NCT07437547Phase 2, randomised, placebo-controlled; 120 planned; recruitingAll18 to 45No“Pregnant or breastfeeding”; people “Currently subject to a formal anti-doping testing program”, unless the relevant authority explicitly approves
NCT07803250Phase 1, randomised; 30 planned; not yet recruiting“Males and Females, 18 years old or older”18, no upper limitNo“Pregnant or breastfeeding status”; hormone or testosterone replacement therapy in the past 12 months

Two records also ask for a negative pregnancy test from participants who could become pregnant. NCT07752381 was completed in November 2025, has posted no results, and we found no publication of it. The two records that take no healthy volunteers enrol patients with a recent muscle injury and patients scheduled for shoulder surgery. A registration is a plan, not a result.

04Were the animal studies in male or female animals?

Most BPC-157 research is in animals. PubMed’s indexers tag each animal study with the sex of the animals used, when the paper reports it.

Sex tag on animal-study records naming BPC-157Records
Male only83
Female only12
Both6
Neither tag8
All animal-study records, humans excluded109

Our count from PubMed’s indexing tags (Animals, Male, Female, Humans), run on 21 November 2026 over 240 records that name BPC-157 or its other names in the title or abstract. Tags can be missing or wrong, so the count describes how the records are indexed, not a reading of every paper. One example: a 2026 tendon study used 32 male rats. FDA staff describe toxicity studies of BPC-157 in rats and dogs of both sexes.

A result in male rats does not show how female animals respond, and an animal result of either sex is not evidence of an effect in people.

05What the BPC-157 studies can’t tell you about sex, age or pregnancy

What the record does not cover, by design.

Whether anything differs by sex

We found no study of BPC-157 that compares women and men (PubMed search for sex-difference terms, 21 Nov 2026). The one all-women study had 12 participants and no control group.

Pregnancy and breastfeeding

We found no human study of BPC-157 in pregnancy (PubMed, 21 Nov 2026), and all four registered trials list pregnancy and breastfeeding among their exclusions.

Older and younger people

Ages are known for 17 participants, the oldest 85. The four registered trials set a minimum age of 18; three set an upper limit, from 35 to 65.

What a vial holds

Material sold online is not the product these studies tested. What a given vial holds is shown only by the identity result on that lot’s report.

How to find that line on a lab report: how to read a COA. Why no page on this site gives an amount for anyone: why we publish no doses.

This is a plain-English summary of public documents and studies, checked on 21 Nov 2026. It is not legal or medical advice.

RefSources

  1. U.S. Food and Drug Administration. FDA briefing document, Pharmacy Compounding Advisory Committee meeting of 23–24 July 2026: BPC-157-related bulk drug substances. Advisory committee briefing, 2026 (pp. 27, 34, 40, 42, 53–55: Appendix 1 and the reference list); downloaded and read 21 Nov 2026 (SHA-1 253cd664…). www.fda.gov/media/193343/download
  2. Lee E, Padgett B. [Retrospective chart review of 17 patients given BPC-157, alone or with thymosin β4.] Altern Ther Health Med, 2021;27(4):8–13. PMID 34324435; abstract read 21 Nov 2026. pubmed.ncbi.nlm.nih.gov/34324435/
  3. Lee E, Walker C, Ayadi B. [Single-arm pilot study of BPC-157 in 12 women.] Altern Ther Health Med, 2024;30(10):12–17. PMID 39325560; abstract read 21 Nov 2026. pubmed.ncbi.nlm.nih.gov/39325560/
  4. Lee E, Burgess K. [Two-person pilot safety study of BPC-157.] Altern Ther Health Med, 2025;31(5):20–24. PMID 40131143; abstract read 21 Nov 2026. pubmed.ncbi.nlm.nih.gov/40131143/
  5. Froum S, Estrin N, Pico G, et al. [Narrative review with three uncontrolled clinical cases given several peptides and other agents.] Front Oral Health, 2026;7:1907109. PMID 42876687; full text PMC13661421 (Table 1) read 21 Nov 2026. pubmed.ncbi.nlm.nih.gov/42876687/
  6. Poolton JT, Minett J, Kazmi A. [Systematic review of human studies of BPC-157, with GRADE certainty ratings.] Acta Orthop Belg, 2026;92(3). PMID 42885452; abstract read 21 Nov 2026. pubmed.ncbi.nlm.nih.gov/42885452/
  7. ClinicalTrials.gov. NCT02637284, NCT07752381, NCT07437547 and NCT07803250: eligibility (sex, minimum and maximum age, healthy volunteers, inclusion and exclusion criteria), status, enrolment and posted-results field. Registry records read through API v2, 21 Nov 2026. clinicaltrials.gov/study/NCT07437547
  8. Biçer O, Adanir O, Güleryüz Y, et al. [BPC-157 and TB-500 in 32 male rats after Achilles tendon transection and repair.] Jt Dis Relat Surg, 2026;37(3):822–837. PMID 42542926; abstract read 21 Nov 2026. pubmed.ncbi.nlm.nih.gov/42542926/
  9. PubMed searches, title and abstract, for BPC-157, BPC 157, BPC157, bepecin, PL 14736, pentadecapeptide BPC, body protection compound and body protective compound (240 records): AND Animals[mh] NOT Humans[mh], 109; of these Male[mh] only 83, Female[mh] only 12, both 6, neither 8; AND pregnancy terms, 1 (a rat toxicology study); AND sex-difference terms, 0. Database searches through E-utilities, 21 Nov 2026. pubmed.ncbi.nlm.nih.gov/?term=%28%22BPC-157%22%5Btiab%5D+OR+…

Plain-English summary of public sources, not legal or medical advice. Last checked 21 Nov 2026.

Questions

Were women included in the BPC-157 studies?

In small numbers. By our count, 15 of the 118 participants in the six published studies we found were women, 12 of them in one study with no control group; the sources do not give the sex of 70 participants.

Has BPC-157 been studied in pregnancy?

We found no human study of BPC-157 in pregnancy (PubMed, 21 Nov 2026). All four registered trials list pregnancy and breastfeeding among their exclusions.

How old were the people in the BPC-157 studies?

The sources give ages for 17 of the 118: 12 women aged 39 to 76, two adults aged 58 and 68, and three patients aged 38, 48 and 85. The four registered trials set a minimum age of 18.

Do any registered BPC-157 trials exclude people tested for doping?

One does: NCT07437547 excludes people “Currently subject to a formal anti-doping testing program”, unless the relevant authority explicitly approves.

Were the BPC-157 animal studies done in male or female animals?

Mostly male, as PubMed indexes them: of 109 animal-study records naming BPC-157, 83 carry only the male tag and 12 only the female tag (our count, 21 Nov 2026).

Evidence before hype.

One email a week: new research explained and regulatory changes. No prices, no hype.

Get the 6:00 brief

Free. Unsubscribe any time.

Written by 6AM Research. Drafted from primary sources; every claim links to its source, and the page is dated. Editorial policy · How we check every page